Diplomat Pharmacy IPO Research Information

Diplomat Pharmacy IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Diplomat Pharmacy, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Diplomat Pharmacy	DPLO - NYSE	$14.00-$16.00	$13.00	$16.00	13.33 million	10/10/2014
Underwriter(s): Credit Suisse, Morgan Stanley
Co-Manager(s): J.P. Morgan, Wells Fargo Securities, William Blair, Leerink Partners
Industry: Health Care
Filing(s): Filed 2014-07-03 Terms Added 2014-09-29

Diplomat Pharmacy Quote & Chart - Click for current quote - DPLO

About Diplomat Pharmacy (adapted from Diplomat Pharmacy prospectus):
They are the nation's largest independent specialty pharmacy and are focused on improving the lives of patients with complex chronic diseases.

This description is adapted from Diplomat Pharmacy prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Diplomat Pharmacy "DPLO" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.